EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Observe Medical ASA's Enterprise Value is €14.57 Mil.
Observe Medical ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.10 Mil. Therefore, Observe Medical ASA's EV-to-FCF for today is -6.94.
The historical rank and industry rank for Observe Medical ASA's EV-to-FCF or its related term are showing as below:
FRA:OM50'
s EV-to-FCF Range Over the Past 10 Years
Min: -25.05 Med: -3.32 Max: -0.86
Current: -6.7
During the past 10 years, the highest EV-to-FCF of Observe Medical ASA was -0.86. The lowest was -25.05. And the median was -3.32.
FRA:OM50's EV-to-FCF is ranked worse than 100% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs FRA:OM50: -6.70
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Observe Medical ASA (FRA:OM50) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Observe Medical ASA's PE Ratio (TTM) for today is calculated as:
Observe Medical ASA's share price for today is €0.0894.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Observe Medical ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.107.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Observe Medical ASA EV-to-FCF Related Terms
Observe Medical ASA EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Observe Medical ASA's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Observe Medical ASA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Observe Medical ASA EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Observe Medical ASA's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Observe Medical ASA's EV-to-FCF falls into.
Observe Medical ASA's current Enterprise Value is €14.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Observe Medical ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Observe Medical ASA (FRA:OM50) has a EV-to-FCF of -6.94 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Observe Medical ASA and its competitors. According to the industry distribution chart, Observe Medical ASA ranks #999999 out of 416 companies in the Medical Devices & Instruments industry.
Is Observe Medical ASA's EV-to-FCF too high?
Observe Medical ASA's current EV-to-FCF is -6.94. Based on the distribution chart, Observe Medical ASA ranks #999999 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Observe Medical ASA has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Observe Medical ASA ranks #999999 out of 416 companies for EV-to-FCF. This places Observe Medical ASA in the lower half of its industry. The industry median EV-to-FCF is 23.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Observe Medical ASA and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Observe Medical ASA's current EV-to-FCF is -6.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Observe Medical ASA (FRA:OM50) has a current EV-to-FCF of -6.94. The stock's GF Value™ is €0.02, compared to a current price of €0.09 — trading 347% above its estimated fair value. The current EV-to-FCF is -6.94. Observe Medical ASA's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Observe Medical ASA (FRA:OM50), the current EV-to-FCF is -6.94 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Observe Medical ASA (FRA:OM50) Overvalued in 2026?
Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued.
The current stock price of €0.09 is trading 347% above its estimated GF Value™ of €0.02.
Key valuation signals for FRA:OM50:
EV-to-FCF: -6.94
GF Value™: €0.02 vs. price of €0.09 (347% above fair value)
No single metric tells the full story. See the FRA:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
32GF Score
Get the complete analysis for FRA:OM50
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OM50 has been successfully added to your 
